Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility

Carcinogenesis

Volumn 18, Issue 12, 1997, Pages 2307-2311

  Esteller, Manel ^a,b   Garcia, Angel ^a   Martinez Palones, Josep Maria ^a   Xercavins, Jordi ^a   Reventos, Jaume ^a,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYTOCHROME P450 ISOENZYME; DNA;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; ENDOMETRIUM CANCER; FEMALE; GENE FREQUENCY; GENE MUTATION; GERM LINE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CARCINOMA; CYTOCHROME P-450 CYP1A1; ENDOMETRIAL NEOPLASMS; FEMALE; GENE FREQUENCY; GERM-LINE MUTATION; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POINT MUTATION; POLYMORPHISM, GENETIC;

EID: 0031431662     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.12.2307     Document Type: Article

References (44)

1. Marra, G. and Boland, C.R. (1995) Hereditary nonpolyposis colorectal cancer: the syndrome, the genes and historical perspectives. J. Natl Cancer Inst., 87, 11-25.
2. Blackwood, M.A. and Weber, B.L. (1996) Recent advances in breast cancer biology. Curr. Opin. Oncol., 8, 449-454.
3. Tomlinson, I.P., Neale, K., Talbot, I.C., Spigelman, A.D., Williams, C.B., Phillips, R.K. and Bodmer, W.F. (1996) A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36. J. Med. Genet., 33, 268-273.
4. Raunio, H., Husgafvel-Pursiainen, K., Anttila, S., Hietanen, E., Hirvonen, A. and Pelkonen, O. (1995) Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review. Gene, 159, 113-121.
5. Kawajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N. and Watanabe, J. (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett., 263, 131-133.
6. Hayashi, S., Watanabe, J., Nakachi, K. and Kawajiri, K. (1991) Genetic linkage of lung cancer-associated Msp I polymorphism with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J. Biochem., 110, 407-411.
7. Crofts, F., Cosma, G., Currie, D., Taioili, E., Toniolo, P. and Garte, S.J. (1993) A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis, 14, 829-831.
8. Nakachi, K., Imai, K., Hayashi., S., Watanabe, J. and Kawajiri, K. (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res., 51, 5177-5180.
9. Ambrosone, C.B., Freudenheim, J.L., Graham, S. et al. (1995) Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res., 55, 3483-3485.
10. Sivaraman, L., Leatham, M.P., Yee, J., Wilkens, L.R., Lau, A.F. and Marchand, L. (1994) CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res., 54, 3692-3695.
11. Reebeck, T.R., Rosvold, E.A., Duggan, D.J., Zhang, J. and Buetow, K.H. (1994) Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer. Cancer Epid. Biomarkers Prev., 3, 511-514.
12. Taioli, E., Trachman, J., Chen, X., Toniolo, P. and Garte, S.J. (1995) A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res., 55, 3757-3758.
13. Esteller, M., Garcia, A., Martinez-Palones, J.M., Xercavins, J. and Reventos, J. (1997) Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci. Br. J. Cancer, 75, 1385-1388.
14. Cascorbi, I., Brockmoller, J. and Roots, I. (1996) A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res., 56, 4965-4969.
15. Kawajiri, K., Nakachi, K., Imai, K., Watanabe, J. and Hayashi, S. (1993) The CYP1A1 gene and cancer susceptibility. Crit. Rev. Oncol. Hematol., 14, 77-87.
16. Krontiris, T., Devlin, B., Karp, D., Robert, N. and Risch, N. (1993) An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N. Engl. J. Med., 329, 517-523.
17. Runnebaum, I.B., Tong, X.W., Konig, R., Hong, Z., Korner, K., Atkinson, E.N., Kreienberg, R. and Kieback, D.G. (1995) p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer. Lancet, 345, 994.
18. Phelan, C.M., Rebbeck, T.R., Weber B.L. et al. (1996) Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeats (VNTR) locus. Nat. Genet., 12, 309-312.
19. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
20. James, S.J., Basnakian, A.G. and Miller, B.J. (1994) In vitro folate deficiency induces deoxynucleotide pool imbalance, apoptosis, and mutagenesis in Chinese hamster ovary cells. Cancer Res., 54, 5075-5080.
21. Blount, B.C. and Ames, B.N. (1995) DNA damage in folate deficiency. Baillieres Clin. Haematol. 8, 461-478.
22. Chen, J., Giovannucci, E., Kelsey, K., Rimm, E.B., Stampfer, M.J., Colditz, G.A., Spiegelman, D., Willet, W.C. and Hunter, D.J. (1996) A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res., 56, 4862-4864.
23. Esteller, M., Garcia, A., Martinez-Palones, J.M., Xercavins, J. and Reventos, J. (1995) Detection of c-erbB-2/neu and fibroblast growth factor-3/int-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction. Cancer, 75, 2139-2145.
24. Frosst, P. Blom, H.J., Milos, R. et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet., 10, 111-113.
25. Schildkraut, J.M. Risch, N. and Thompson, W.D. (1989) Evaluating genetic association among ovarian, breast and endometrial cancer: evidence for a breast/ovarian cancer relationship. Am. J. Hum. Genet., 45, 521-529.
26. Selhub, J. and Miller, J.W. (1992) The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am. J. Clin. Nutr., 55, 131-138.
27. Laird, P.W. and Jaenisch, R. (1996) The role of DNA methylation in cancer genetics and epigenetics. Annu. Rev. Genet., 30, 441-464.
28. Ben-Baruch, G., Solomon, R., Menczer, J. and Kloog, Y. (1988) High levels of protein carboxyl methyltransferase in well-differentiated human endometrial carcinoma. FEBS Lett., 228, 277-280.
29. Kleinz, Z., Ben-Baruch, G., Marciano, D., Solomon, R., Altaras, M. and Kloog, Y. (1994) Characterization of the prenylated protein methyltransferase in human endometrial carcinoma. Biochim. Biophys. Acta, 3, 330-336.
30. Piva, R., Kumar, V.L., Hanau, S., Rimondi, A.P., Pansini, S., Mollica, G. and del Senno, L. (1989) Abnormal methylation of estrogen receptor gene and reduced estrogen receptor RNA levels in human endometrial carcinomas. J. Steroid. Biochem., 32, 1-4.
31. Blount, B.C. and Ames, B.N. (1994) Analysis of uracil in DNA by gas chromatography-mass spectrometry. Anal. Biochem., 219, 195-200.
32. Reidy, J.A. (1988) Role of deoxyuridine incorporation and DNA repair in the expression of human chromosomal fragile sites. Mutat. Res., 200, 215-220.
33. Weinberg, R.A. (1988) The genetic origins of human cancer. Cancer, 61, 1963-1968.
34. Nisker, J.A., Ramzy, I. and Collins, J.A. (1978) Adenocarcinoma of the endometrium and abnormal ovarian function in young women. Am. J. Obstet. Gynecol., 130, 9-13.
35. Lippman., M.E. and Swain, S.M. (1992) Endocrine-responsive cancers of human. In Wilson, D.J. and Foster, D.W. (eds) Textbook of Endocrinology, W.B. Saunders, Philadelphia, pp. 1577-1598.
36. Schneider, J., Huh, M.M., Bradlow, L.H. and Fishman, J. (1984) Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J. Biol. Chem., 259, 4840-4845.
37. Nebert, D.W. (1991) Role of genetics and drug metabolism in human cancer risk. Mutat. Res., 247, 267-281.
38. Calaf, G. and Russo, J. (1993) Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis, 15, 483-492.
39. Kulkarni, M.S., Calloway, K., Irigaray, M.F. and Kaufman, D.G. (1986) Species differences in the formation of benzo(a)pyrene-DNA adducts in rodent and human endometrium. Cancer Res., 46, 2888-2891.
40. Marshall, C.J., Vousden, K.H. and Phillips, D.H. (1984) Activation of c-Ha-ras-1 proto-oncogene by in vitro modification with a chemical carcinogen, benzo(a)pyrene diol-epoxide. Nature, 310, 586-589.
41. Berchuck, A. and Boyd, J. (1995) Molecular basis of endometrial cancer. Cancer, 76, 2034-2040.
42. Sasaki, H., Nishii, H., Takahashi, H., Furusato, M., Terashima, Y. and Siegal, G.P. (1993) Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res., 53, 1906-1910.
43. Esteller, M., Garcia, A., Martinez-Palones, J.M., Xercavins, J. and Reventos, J. (1997) Detection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart. Lab. Invent., 76, 109-116.
44. Kurman, R.J., Zaino, R.J. and Norris, H.J. (1994) Endometrial carcinoma. In Kurman, R.J. (ed) Blaustein's Pathology of the Female Genital Tract. Springer-Verlag, New York, pp. 439-486.